Global Retirement Partners’s Abeona Therapeutics ABEO Stock Holding History

Global Retirement Partners’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6	Closed	-$18	–	3189
2022 Q4	$18	Hold	6	–	–	﹤0.01%	3011
2022 Q3	$0	Buy	+6	New	+$25	﹤0.01%	2660
2022 Q2	–	Hold	0	–	–	–	2656
2022 Q1	–	Hold	0	–	–	–	2609
2021 Q4	–	Hold	0	–	–	–	258
2021 Q3	–	Hold	0	–	–	–	1971
2021 Q2	–	Hold	0	–	–	–	1854
2021 Q1	–	Hold	0	–	–	–	1762
2020 Q4	–	Hold	0	–	–	–	1722
2020 Q3	–	Hold	0	–	–	–	1614
2020 Q2	–	Hold	0	–	–	–	1593
2020 Q1	–	Hold	0	–	–	–	1565
2019 Q4	–	Hold	0	–	–	–	1601
2019 Q3	–	Hold	0	–	–	–	1587
2019 Q2	–	Hold	0	–	–	–	1583
2019 Q1	–	Hold	0	–	–	–	1510
2018 Q4	–	Hold	0	–	–	–	1447
2018 Q3	–	Hold	0	–	–	–	1523
2018 Q2	–	Hold	0	–	–	–	1516
2018 Q1	–	Hold	0	–	–	–	1474
2017 Q4	–	Hold	0	–	–	–	1420
2017 Q3	–	Hold	0	–	–	–	1205
2017 Q2	–	Hold	0	–	–	–	1135

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Global Retirement Partners's ABEO Position: Q1 2023 in Review

Global Retirement Partners sold out of Abeona Therapeutics (ABEO) in Q1 2023, closing a stake of 6 shares — an estimated $18 sold.

Global Retirement Partners first reported a position in ABEO in Q3 2022 and held it in 2 quarters. The position peaked at $18 in Q4 2022. 33 funds tracked by Wall St. Rank hold ABEO as of Q1 2023.

Global Retirement Partners reported no remaining Abeona Therapeutics position as of Q1 2023 after selling out during the quarter.
Global Retirement Partners sold 6 Abeona Therapeutics shares in Q1 2023, an estimated $18.
Global Retirement Partners first reported a position in Abeona Therapeutics in Q3 2022 and held it in 2 quarters.
Global Retirement Partners's Abeona Therapeutics position peaked at $18 in Q4 2022.
33 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2023.

Based on Global Retirement Partners's 13F filing for Q1 2023, filed 8 May 2023.